Anna Stengel

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 6

Top Topics

Transcription Factor

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

Journal of cancer research and clinical oncology

Genes, chromosomes & cancer

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Janine Müller, Wencke Walter, Claudia Haferlach, Heiko Müller, Irene Fuhrmann, Martha-Lena Müller, Henning Ruge, Manja Meggendorfer, Wolfgang Kern, Torsten Haferlach, Anna Stengel
Correction: How T-lymphoblastic leukemia can be classified based on genetics using standard diagnostic techniques enhanced by whole genome sequencing. Leukemia (2022)
Janine Müller, Wencke Walter, Claudia Haferlach, Heiko Müller, Irene Fuhrmann, Martha-Lena Müller, Henning Ruge, Manja Meggendorfer, Wolfgang Kern, Torsten Haferlach, Anna Stengel
Correction: How T-lymphoblastic leukemia can be classified based on genetics using standard diagnostic techniques enhanced by whole genome sequencing. Leukemia (2022)
Janine Müller, Wencke Walter, Claudia Haferlach, Heiko Müller, Irene Fuhrmann, Martha-Lena Müller, Henning Ruge, Manja Meggendorfer, Wolfgang Kern, Torsten Haferlach, Anna Stengel
How T-lymphoblastic leukemia can be classified based on genetics using standard diagnostic techniques enhanced by whole genome sequencing. Leukemia (2022)
Luise Hartmann, Claudia Haferlach, Manja Meggendorfer, Wolfgang Kern, Torsten Haferlach, Anna Stengel
Myeloid malignancies with isolated 7q deletion can be further characterized by their accompanying molecular mutations. Genes, chromosomes & cancer 58 (10) (2019)
Bettina Balk, Torsten Haferlach, Manja Meggendorfer, Wolfgang Kern, Claudia Haferlach, Anna Stengel
Impact of 9q deletions on the classification of patients with acute myeloid leukemia. Journal of cancer research and clinical oncology 145 (11) (2019)
Anna Stengel, Wolfgang Kern, Manja Meggendorfer, Torsten Haferlach, Claudia Haferlach
Detailed molecular analysis and evaluation of prognosis in cases with high grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements. British journal of haematology 185 (5) (2018)